Institutional investors purchased a net $529.2 thousand shares of TTNP during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 16.89% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 156.7 Thousand shares of Titan Pharmaceuticals Inc